Drug Delivery Devices Market Segmentation:
Route of Administration Segment Analysis
The injectable segment in the drug delivery devices market is estimated to gain the largest revenue share of about 39% in the year 2035.advances in injectable drug delivery techniques, such as the advent of prefilled syringes and pen injection devices, have boosted demand. Furthermore, the advancement of substances for syringes such as polymers, which are inert to most chemicals, is driving market expansion. In addition, the global vaccination effort, which is increasing syringe use, is expected to contribute to segmental development in the near future. For example, Becton, Dickinson, and Company (BD) announced in 2021 that it had obtained pandemic orders for syringes, and needles totaling 2 billion injectable equipment to support global COVID-19 vaccination initiatives.
Distribution Channel Segment Analysis
The hospital segment is expected to garner a significant share of around 30% in the year 2035. Also, the hospital segment had the greatest share in 2022, owing to an increase in cancer, diabetes, and neurological illnesses. Patients hospitalized in the hospital with varied diseases require different pharmaceuticals for therapy, which are administered by various drug delivery approaches. In addition, the availability of contemporary medical equipment, as well as patients' overwhelming desire for receiving care in a hospital setting, are expected to drive category growth.
Our in-depth analysis of the global market includes the following segments:
|
Device Type
|
|
|
Route of Administration
|
|
|
Distribution Channel
|
|
